Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
NDTV
India has joined a select group of countries where the HPV vaccine is to be manufactured in the next four or five months.
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country, said Dr NK Arora, chairman of the Covid working group, National Technical Advisory Group on Immunisation (NTAGI), on Tuesday.
Speaking to ANI, Dr Arora said, "There are two or three companies which are in the process (of manufacturing the vaccine in India) but the Serum Institute of India (SII) has already got the regulators' clearance and the vaccine should be available for our patients by April or May 2023."
"The vaccine should be available soon. I don't know the exact cost yet but am given to understand that the cost of the vaccine will be one-tenth of the internationally-branded vaccine currently available," he added.
Dr Arora further informed that almost 80,000 cases of cervical cancer occur in India every year.
